Overview

Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients

Status:
Completed

Trial end date:
0000-00-00

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate skin graft adherence and wound healing in burn patients to evaluate whether FS 4IU VH S/D is equivalent or superior to the current standard of care (staples). The primary endpoint is achievement of complete (100%) wound closure within 28 days.

Phase:

Phase 3

Details

Lead Sponsor:

Baxter Healthcare Corporation

Treatments:

Fibrin Tissue Adhesive
Thrombin